$GNCA GENOCEA BIOSCIENCES, INC. Insider Trading
Get free email notifications about insider trading in GENOCEA BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENOCEA BIOSCIENCES, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in GENOCEA BIOSCIENCES, INC. for free.
CIK Number: 0001457612
IRS Number: 510596811
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: GNCA
Company Address: 100 ACORN PARK DRIVE CAMBRIDGE 02140
Phone number: 617-876-8191
Former name: GENOCEA BIOSCIENCES INC, date of change: 2009-03-04
Market Capitalization: $129.13M
Prev close: $4.51
Average Daily Volume: 198,748
Days Low: $4.45
Year Low: $2.65
Year High: $8.07
GENOCEA BIOSCIENCES, INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Option Exercise | A | 3.01 | 112,500 | 338,625 | 112,500 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Duvall Diantha | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 37,500 | 0 | 37,500 | 0 to 37.5 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 0.00 | 600,000 | 0 | 600,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 3.01 | 450,000 | 1,354,500 | 450,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Grant | A | 0.00 | 150,000 | 0 | 150,000 | 0 to 150 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Option Exercise | A | 3.01 | 131,250 | 395,063 | 131,250 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | Chief Scientific Of ... | Grant | A | 0.00 | 43,750 | 0 | 43,750 | 0 to 43.8 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 3.01 | 93,750 | 282,188 | 93,750 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Option Exercise | A | 3.01 | 93,750 | 282,188 | 93,750 | |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Grant | A | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |
Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Aakalu Girish N | CHIEF BUSINESS OFFI ... | Grant | A | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |